Suppr超能文献

儿童门静脉高压症时的胃肠道蛋白丢失。

Gastrointestinal protein loss in children with portal hypertension.

机构信息

Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Indian J Gastroenterol. 2021 Jun;40(3):333-337. doi: 10.1007/s12664-020-01079-y. Epub 2020 Sep 24.

Abstract

Portal hypertension increases pressure in lymphatic ducts, which may lead to gastrointestinal (GI) protein loss. Reports have shown that adults with portal hypertension had resolution of protein-losing enteropathy after transplantation; but studies in children are very limited. We therefore aimed to evaluate GI protein loss in children with portal hypertension and defined changes after liver transplantation. Children aged 3 months to 18 years with portal hypertension and the age-matched healthy controls were enrolled during August 2018 to September 2019. Random fecal alpha-1 antitrypsin measurements were obtained at the initial visit, 3 months later, 1 week before, and 3 months after liver transplantation (if applicable). One or more positive test (> 0.795 mg/dL) was interpreted as a positive result. We enrolled 76 children (n = 38 in each group) with a median age of 15.5 months (interquartile range [IQR], 11.2-41.7), female 51%, and 92% with biliary atresia in the portal hypertension group. We noted GI protein loss in 4/38 children (10.5%) with portal hypertension, while none in the controls (p = 0.11). We found no significant differences on the markers of severity of liver disease and serum albumin between patients with vs. the ones without GI protein loss (p > 0.05). After liver transplantation, 2/4 patients with GI protein loss had undetectable loss. We found that, in a small group of children, 10.5% with portal hypertension had notable GI protein loss without significant relationships with the severity of liver disease.

摘要

门静脉高压症会增加淋巴管内的压力,这可能导致胃肠道(GI)蛋白丢失。有报道称,患有门静脉高压症的成年人在接受移植后可治愈蛋白丢失性肠病;但儿童的相关研究非常有限。因此,我们旨在评估门静脉高压症患儿的 GI 蛋白丢失情况,并确定肝移植后的变化。2018 年 8 月至 2019 年 9 月期间,我们招募了患有门静脉高压症且年龄匹配的健康对照组的 3 个月至 18 岁儿童。在初次就诊、3 个月后、肝移植前 1 周和 3 个月后(如果适用),随机采集粪便α-1 抗胰蛋白酶进行测量。一个或多个阳性检测(>0.795mg/dL)被解释为阳性结果。我们共招募了 76 名儿童(每组 38 名),中位年龄为 15.5 个月(四分位间距 [IQR],11.2-41.7),女性占 51%,92%患有胆道闭锁。我们在门静脉高压症组的 4/38 名儿童(10.5%)中发现了 GI 蛋白丢失,而对照组中则没有(p=0.11)。在有和没有 GI 蛋白丢失的患者之间,我们没有发现肝脏疾病严重程度和血清白蛋白的标志物有显著差异(p>0.05)。肝移植后,4 名有 GI 蛋白丢失的患者中有 2 名丢失量不可检测。我们发现,在一小部分儿童中,10.5%患有门静脉高压症的儿童有明显的 GI 蛋白丢失,但与肝脏疾病的严重程度无明显关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验